2014 proved to be another busy year for the FDA. We asked Barbara Unger, President of Unger Consulting and Editor-in-Chief of GMP Regulatory Intelligence, to summarize
I hope you read our recent post about the backstory of our company, FDAzilla. We’ve come a long way in 5 years. As we plan
This week, I got a chance to ask our new editor-in-chief of GMP Regulatory Intelligence a few questions. Her responses were so thorough and insightful
It has been quite a year for FDA 483s and Warning Letters. Here are the top 5 stories for 2013:
The government is still shut down, though the FDA is still about half-open. The question is: which half? The government shutdown is now on day
I started the QAPharm Blog three years ago as a creative outlet to share my perspective on the pharma industry and the quality assurance profession.